Ticker Scorecard - CSTL Basics Company: Castle Biosciences, Inc. IPO Date: July 22, 2019 Sector: Healthcare Market Cap: $721.19M Activated in VL: True Average Daily Range Avg Daily Range: $1.06 | 3.08% Avg Daily Range (30 D): $0.67 | 2.39% Avg Daily Range (90 D): $0.73 | 2.43% Institutional Daily Volume Avg Daily Volume: .23M Avg Daily Volume (30 D): .38M Avg Daily Volume (90 D): .33M Trade Size Avg Trade Size (Sh.): 58 Avg Trade Size (Sh.) (30 D): 56 Avg Trade Size (Sh.) (90 D): 52 Institutional Trades Total Inst.Trades: 1,091 Avg Inst. Trade: $1.29M Avg Inst. Trade (30 D): $1.34M Avg Inst. Trade (90 D): $1.37M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.41M Avg Closing Trade (30 D): $1.58M Avg Closing Trade (90 D): $1.48M Avg Closing Volume: 40.77K     News Nov 22, 2024 @ 7:27 AM Gene Panel Market to Surpass USD 11.75 Billion by ... Source: Skyquest Jul 22, 2024 @ 1:00 PM Zacks Market Edge Highlights: Soundhound AI, Afya,... Source: Zacks.Com Jul 8, 2024 @ 12:40 PM Top 5 Health Care Stocks That May Explode In July ... Source: Avi Kapoor Jun 21, 2024 @ 12:24 PM Top 5 Small-Cap Biotechnology Stocks for a Stable ... Source: Nalak Das Jun 13, 2024 @ 1:40 PM Is Castle Biosciences (CSTL) Outperforming Other M... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $.22 $.08 $.32 Diluted EPS $.21 $.08 $.31 Revenue $ 311.88M $ 85.78M $ 87M Gross Profit $ 255.43M $ 70.17M $ 72.48M Net Income / Loss $ 6.08M $ 2.27M $ 8.92M Operating Income / Loss $ -1.04M $ 5.08M $ 5.01M Cost of Revenue $ 56.45M $ 15.61M $ 14.52M Net Cash Flow $ 3.74M $ 9.39M $ 2.62M PE Ratio 122.62